It is a rare type of pituitary apoplexy.

这是一种罕见的脑垂体卒中。

The investigators report that among patients with acute anterior circulation large vessel occlusion stroke who achieved successful endovascular reperfusion by thrombectomy, receipt of intra-arterial alteplase resulted in a higher likelihood of excellent functional outcomes at 90 days.

研究人称，在急性前循环大血管闭塞性卒中患者中，那些通过血栓切除术成功实现血管再通的患者，接受动脉内阿替普酶治疗后，90天时获得良好功预后的性更高。

In our patients that we've treated in multiple trials, we're seeing early indications that patients years out from a stroke, can start to recover function in their arms, in their legs, in their speech.

在我们治疗过的多个试验患者中，我们看早期迹象表明，卒中多年后的患者开始够恢复手臂、腿部和言语的功。

Like if they can get help quickly, the better chance is that, you know, they will recover from the stroke and not have as many complications.

因此，我认为这是速度问题的一部分。 比如，如果他们迅速得帮助， 那么，你知道的，他们更有卒中中恢复过来，并且不会出现那么多并发症。

The major source of thromboembolism and stroke in non-valvular AFib is formation of thrombus in the left atrial appendage where flow is relatively stagnant.

非瓣膜性房颤中，血栓栓塞和卒中的主要来源是左心耳内血栓的形成，此处血流相对滞缓。

Although differential diagnoses such as abscess or non-tumor-induced stroke must be considered, new neurological symptoms in a patient with NSCLC should be suspected to be related to the known cancer until proven otherwise.

尽管必须考虑鉴别诊断，如脓肿或非肿瘤诱发的卒中，但除非另有证明，否则应怀疑 NSCLC 患者的新发神经系统症状与已知癌症有关。

Let's turn to JAMA's newest stroke trial, the PERL randomized clinical trial.

让我们来看看JAMA最新的一项卒中试验，即PERL随机临床试验。

Dr. Tang and colleagues evaluated whether intra-arterial alteplase could improve functional outcomes in patients after successful reperfusion following acute stroke.

唐医生及其同事评估了在急性卒中患者成功再灌注后，动脉内注射阿替普酶是否改善功预后。